Northern Trust’s Microbot Medical MBOT Stock Holding History

Northern Trust’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$345K	Buy	143,360 +29,155	+26%	+$65.1K	﹤0.01%	3754
2025 Q4	$228K	Buy	114,205 +34,099	+43%	+$80.8K	﹤0.01%	3933
2025 Q3	$244K	Buy	80,106 +9,051	+13%	+$28.2K	﹤0.01%	3912
2025 Q2	$179K	Hold	71,055	–	–	﹤0.01%	3973
2025 Q1	$107K	Buy	71,055 +57,668	+431%	+$102K	﹤0.01%	4097
2024 Q4	$15K	Hold	13,387	–	–	﹤0.01%	4399
2024 Q3	$12K	Hold	13,387	–	–	﹤0.01%	4370
2024 Q2	$13.7K	Sell	13,387 -59	-0.4%	-$61	﹤0.01%	4359
2024 Q1	$16.5K	Hold	13,446	–	–	﹤0.01%	4355
2023 Q4	$22.1K	Hold	13,446	–	–	﹤0.01%	4354
2023 Q3	$18.7K	Hold	13,446	–	–	﹤0.01%	4339
2023 Q2	$36.6K	Hold	13,446	–	–	﹤0.01%	4289
2023 Q1	$28K	Buy	13,446 +3,017	+29%	+$8.93K	﹤0.01%	4384
2022 Q4	$31.4K	Hold	10,429	–	–	﹤0.01%	4393
2022 Q3	$50K	Hold	10,429	–	–	﹤0.01%	4321
2022 Q2	$54K	Hold	10,429	–	–	﹤0.01%	4382
2022 Q1	$65K	Sell	10,429 -1,449	-12%	-$8.49K	﹤0.01%	4471
2021 Q4	$89K	Hold	11,878	–	–	﹤0.01%	4456
2021 Q3	$84K	Hold	11,878	–	–	﹤0.01%	4442
2021 Q2	$94K	Hold	11,878	–	–	﹤0.01%	4375
2021 Q1	$101K	Buy	11,878 +113	+1%	+$972	﹤0.01%	4283
2020 Q4	$81K	Buy	11,765 +880	+8%	+$6.6K	﹤0.01%	4155
2020 Q3	$83K	Sell	10,885 -1,860	-15%	-$13.1K	﹤0.01%	4003
2020 Q2	$88K	Sell	12,745 -14	-0.1%	-$95	﹤0.01%	3948
2020 Q1	$71K	Buy	+12,759	New	+$112K	﹤0.01%	3885
2018 Q3	–	Sell	-1,004	Closed	-$11K	–	4325
2018 Q2	$11K	Hold	1,004	–	–	﹤0.01%	4245
2018 Q1	$10K	Hold	1,004	–	–	﹤0.01%	4202
2017 Q4	$15K	Buy	1,004 +7	+0.7%	+$119	﹤0.01%	4176
2017 Q3	$17K	Hold	997	–	–	﹤0.01%	4168
2017 Q2	$21K	Hold	997	–	–	﹤0.01%	4177
2017 Q1	$87K	Buy	+997	New	+$87.6K	﹤0.01%	3987
2016 Q4	–	Sell	-81	Closed	-$15K	–	4201
2016 Q3	$15K	Hold	81	–	–	﹤0.01%	4121
2016 Q2	$4K	Hold	81	–	–	﹤0.01%	4191
2016 Q1	$35K	Hold	81	–	–	﹤0.01%	4070
2015 Q4	$55K	Hold	81	–	–	﹤0.01%	4037
2015 Q3	$53K	Buy	81 +17	+27%	+$12.9K	﹤0.01%	4058
2015 Q2	$56K	Sell	64 -13	-17%	-$15.3K	﹤0.01%	4057
2015 Q1	$127K	Hold	77	–	–	﹤0.01%	3986
2014 Q4	$117K	Hold	77	–	–	﹤0.01%	3950
2014 Q3	$157K	Buy	77 +21	+38%	+$55.4K	﹤0.01%	3909
2014 Q2	$185K	Hold	56	–	–	﹤0.01%	3874
2014 Q1	$121K	Buy	56 +7	+14%	+$16.7K	﹤0.01%	3904
2013 Q4	$99K	Sell	49 -1	-2%	-$2.12K	﹤0.01%	3869
2013 Q3	$136K	Buy	50 +4	+9%	+$10.9K	﹤0.01%	3749
2013 Q2	$124K	Buy	+46	New	+$130K	﹤0.01%	3765

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Northern Trust's MBOT Position: Q1 2026 in Review

Northern Trust increased its Microbot Medical (MBOT) stake by 26% in Q1 2026, buying an estimated $65.1K and bringing the position to 143,360 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #3754.

Northern Trust first reported a position in MBOT in Q2 2013 and has held it in 45 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

Northern Trust held 143,360 shares of Microbot Medical worth $345K as of Q1 2026.
Northern Trust bought 29,155 Microbot Medical shares in Q1 2026, an estimated $65.1K.
Microbot Medical made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3754 holding.
Northern Trust first reported a position in Microbot Medical in Q2 2013 and has held it in 45 quarters since.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.